TraceLink Overview

  • Founded
  • 2009
Founded
  • Status
  • Private
  • Employees
  • 570
Employees
  • Latest Deal Type
  • Series D
  • Latest Deal Amount
  • $93M
Latest Deal Amount
  • Investors
  • 9

TraceLink General Information

Description

Provider of an online medical platform intended to track and trace pharmaceuticals easily. The company's SaaS platform uses cloud to connect the life sciences supply chain and eliminate the counterfeit prescription drugs from the global marketplace, enabling manufacturers, distributors and dispensers to secure their drug supply chain and stop the trade of counterfeit medicines.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Business/Productivity Software
Other Industries
Logistics
Primary Office
  • 400 Riverpark Drive
  • Suite 200
  • North Reading, MA 01864
  • United States
+1 (781) 000-0000

TraceLink Timeline

2017201820192020
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

TraceLink Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC (Series D) 21-Aug-2018 $93M 00000 00000 Completed Generating Revenue
4. Later Stage VC (Series C) 30-Nov-2016 000.00 000.00 00000 Completed Generating Revenue
3. Later Stage VC (Series B) 18-Feb-2015 0000 000.00 00000 Completed Generating Revenue
2. Later Stage VC 08-Jan-2014 $5.5M $9.2M Completed Startup
1. Early Stage VC 19-Aug-2013 $3.66M $3.66M Completed Startup
To view TraceLink’s complete valuation and funding history, request access »

TraceLink Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series D 0,000,000 00.000000 00.00 000.00 000.00 00 000.00 0.000
Series C 0,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
Series B 0,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
Series A2 0,000,000 00.000000 00.00 00.00 00.00 00 00.00 0.000
Series A1 4,891,567 $0.000100 $0.06 $0.78 $0.78 1x $0.78 12.84%
Series A 5,152,302 $0.000100 $0.03 $0.33 $0.33 1x $0.33 13.52%
To view TraceLink’s complete cap table history, request access »

TraceLink Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Provider of an online medical platform intended to track and trace pharmaceuticals easily. The company's SaaS platform u
Business/Productivity Software
North Reading, MA
570 As of 2020
00000
0000 0000-00-00
00000000000 00000

00000000

inim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis
000000000000000000000 00000000
San Mateo, CA
000 As of 0000
0000
0000000000 0 0000

00000

um dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore
000000000000000000000 00000000
Marlton, NJ
000 As of 0000
00000
00000000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

TraceLink Competitors (25)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Elementum Venture Capital-Backed San Mateo, CA 000 0000 0000000000 0 0000
00000 Venture Capital-Backed Marlton, NJ 000 00000 00000000000 00000
000000000 Venture Capital-Backed New York, NY 00000 00000
00000 000000000 Corporation
000000000 Private Equity-Backed San Francisco, CA 00 000.00 000000000000 000.00
You’re viewing 5 of 25 competitors. Get the full list »

TraceLink Executive Team (31)

Name Title Board Seat Contact Info
Shabbir Dahod Co-Founder, President, Chief Executive Officer and Board Member
Michael Mozzer Chief Financial Officer
Bob Sturim Chief Technology Officer
John Kordash Senior Vice President, Cloud & Chief Information Officer
Kevin Young Chief Marketing Officer
You’re viewing 5 of 31 executive team members. Get the full list »

TraceLink Board Members (10)

Name Representing Role Since
Amish Jani FirstMark Capital Board Member 000 0000
Jack Cooper Self Board Member 000 0000
Jason Kreuziger The Goldman Sachs Group Board Member 000 0000
Lawrence Lenihan Jr. Self Board Member 000 0000
Sean Cantwell Volition Capital Board Member 000 0000
You’re viewing 5 of 10 board members. Get the full list »

TraceLink Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

TraceLink Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Georgian Partners Venture Capital Minority 000 0000 000000 0
Vulcan Capital PE/Buyout Minority 000 0000 000000 0
Willett Advisors Family Office Minority 000 0000 000000 0
The Goldman Sachs Group Investment Bank Minority 000 0000 000000 0
F-Prime Capital Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 9 investors. Get the full list »

TraceLink Acquisitions (2)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000 00 000000000 01-Aug-2017 000000000000000000 Business/Productivity Software 0000000 00000
SupplyScape 02-Sep-2009 Merger/Acquisition Laboratory Services (Healthcare) 0000000 00000
To view TraceLink’s complete acquisitions history, request access »